For the 2014 D&D 5E by Roll20 PC sheet. The game creator needs Pro and ChatSetAttr. Select a token linked to the destination character and paste each command into chat one at a time, in order.
Adds a spell with its details. Simple structured attack or save damage and per-slot damage scaling create a linked Roll20 roll; other spells stay descriptive cards. Set preparation and spellcasting ability on the character as needed. Check the resulting roll, especially conditional effects. Re-running adds another spell.
!setattr --sel --repeating_spell-7_-CREATE_spellname|Regenerate --repeating_spell-7_-CREATE_spelllevel|7 --repeating_spell-7_-CREATE_spellschool|transmutation --repeating_spell-7_-CREATE_spellcastingtime|1 Minute --repeating_spell-7_-CREATE_spellrange|Touch --repeating_spell-7_-CREATE_spellcomp_v|{{v=1}} --repeating_spell-7_-CREATE_spellcomp_s|{{s=1}} --repeating_spell-7_-CREATE_spellcomp_m|{{m=1}} --repeating_spell-7_-CREATE_spellcomp_materials|a prayer wheel --repeating_spell-7_-CREATE_spellritual|0 --repeating_spell-7_-CREATE_spellconcentration|0 --repeating_spell-7_-CREATE_spellduration|1 hour --repeating_spell-7_-CREATE_spelldescription|A creature you touch regains 4d8 + 15 Hit Points. For the duration, the target regains 1 Hit Point at the start of each of its turns, and any severed body parts regrow after 2 minutes. --repeating_spell-7_-CREATE_spellathigherlevels| --repeating_spell-7_-CREATE_spelloutput|SPELLCARD
A creature you touch regains 4d8 + 15 Hit Points. For the duration, the target regains 1 Hit Point at the start of each of its turns, and any severed body parts regrow after 2 minutes.
Otto's Irresistible Upcasting
adds
Variants
to this creature.
View
Search by name, or choose a recently opened entry.
Add to…
esc
Full-text search — matches in entries, pages, notes and your uploaded documents. Filter with @ and #; start with ! to search everything you can access.
Type to search the full text of everything you can access, including uploaded documents.
Discussion
Log in to join the discussion.
No comments yet. Start the discussion.